Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MCHR1 | Q99705 | 17/20 | 0.44 |
| ▸ | ADRA2A | P08913 | 13/20 | 0.44 |
| ▸ | HRH1 | P35367 | 7/20 | 0.41 |
| ▸ | HTR2B | P41595 | 7/20 | 0.41 |
| ▸ | HTT | P42858 | 2/20 | 0.39 |
| ▸ | RAB9A | P51151 | 1/20 | 0.39 |
| ▸ | ADRA1A | P35348 | 4/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 1/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HTR1A | P08908 | 1/20 | 0.37 |
| ▸ | NPY5R | Q15761 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6464817 | 1.00 | MCHR1 (0.44) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6868128 | 0.90 | MCHR1 (0.46) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6874204 | 0.90 | RAB9A (0.54) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6874197 | 0.90 | RAB9A (0.54) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6868122 | 0.90 | MCHR1 (0.46) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6867547 | 0.89 | MAPT (0.47) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6867543 | 0.89 | MAPT (0.47) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6875821 | 0.89 | MCHR1 (0.41) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6875825 | 0.89 | MCHR1 (0.41) | MCHR1ADRA2AHRH1HTR2BHTT | |
| SCHEMBL6876604 | 0.89 | MCHR1 (0.42) | MCHR1ADRA2AHRH1HTR2BHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2004087669-A1 | NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO. LTD. (JP) | 2004-10-14 | — | — | WO | claimed |
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | claimed |
| WO-2004087669-A1 | NOVEL QUINOLINE, TETRAHYDROQUINAZOLINE, AND PYRIMIDINE DERIVATIVES AND METHODS OF TREATMENT RELATED TO THE USE THEREOF | TAISHO PHARMACEUTICAL CO. LTD. (JP) | 2004-10-14 | — | — | WO | disclosed |
| EP-1464335-A2 | Quinoline, tetrahydroquinoline and pyrimidine derivatives as mch antagonist | Taisho Pharmaceutical Co. Ltd. (JP) | 2004-10-06 | — | — | EP | disclosed |